From 18-20 September, Neuraxpharm attended the 40th joint ECTRIMS congress (European Committee for Treatment and Research in Multiple Sclerosis) in Copenhagen with its partner TG Therapeutics. ECTRIMS is the world’s largest Multiple Sclerosis meeting, and this year brought together around 9,000 neurologists and MS experts from more than 100 countries.
The Neuraxpharm team had the opportunity to connect face to face with the global MS community and showcase its initiatives to support those living with MS. Neuraxpharm and TG Therapeutics were present at the congress with a large scientific booth featuring the latest information on MS therapy and interesting booth talks delivered by leading MS experts generated high interest among neurologists. In addition, new scientific data on the treatment of MS was presented by our partner TG Therapeutics.
As a leading European pharmaceutical company focused on the central nervous system, Neuraxpharm is fully committed to improving the quality of life of people living with #MultipleSclerosis.
